돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 336005생성일: 2026년 10월 24일

4,4-Difluoropiperidine hydrochloride → (S)-3-(4,4-difluoropiperidin-1-yl)-1-fluoro-7-(5-fluoropyridin-3-yl)-5'-H-spiro[chromeno[2,3-c]pyridine-5,4'-oxazol]-2'-amine

https://huagongshe.com/ko/reaction/336005

반응식

참여 물질

역할이름HCID투입량
반응물4,4-Difluoropiperidine hydrochlorideHCID 2758351—
반응물(5-Fluoropyridin-3-yl)boronic acidHCID 44717403—
반응물(S)-7-bromo-3-chloro-1-fluoro-5'H-spiro[chromeno[2,3-c]pyridine-5,4' oxazol]-2'-amineHCID 58466258—
생성물(S)-3-(4,4-difluoropiperidin-1-yl)-1-fluoro-7-(5-fluoropyridin-3-yl)-5'-H-spiro[chromeno[2,3-c]pyridine-5,4'-oxazol]-2'-amineHCID 53464568—

반응 단계

The title compound was synthesized by steps analogous to those described in method CC4 above, but using (S)-7-bromo-3-chloro-1-fluoro-5′H-spiro[chromeno[2,3-c]pyridine-5,4′-oxazol]-2′-amine (prepared as described in Method BB33), 5-fluoropyridin-3-ylboronic acid and 4,4-difluoropiperidine hydrochloride.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08883782B2
출처 데이터셋uspto-grants-2014_11
ORD IDord-7f0c6171adf14c4b90682fe640372ded
출처 메모uspto-grants-2014_11